Xiaofei Liang

6PUBLICATIONS
7CO-AUTHORS
Molecular targetsClinical pharmacology and therapeuticsPharmacogenomicsEpidemiological methodsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Discovery of Dihydropyrimido-Pyrimidine-Based Bone Marrow Tyrosine Kinase Gene in Chromosome X Protein Proteolysis-Targeting Chimeras for the Treatment of Prostate Cancer.

|Aug 20, 2024
Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors.

Chun Wang, Fengming Zou, Ziping Qi

|Nov 08, 2021
Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics.

Dominik Wüllner, Maren Gesper, Annika Haupt

|Oct 19, 2021
Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas.

Bin Zhou, Xiaofei Liang, Husheng Mei

|Nov 12, 2020
Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease.

Feng Li, Xiaofei Liang, Zongru Jiang

|Dec 20, 2018
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia.

Xiaofei Liang, Beilei Wang, Cheng Chen

Pageof 1

Frequent Collaborators

5 joint publications

Jing Liu

5 joint publications

Qingsong Liu

1 joint publications

Ellen L Weisberg

1 joint publications

Dominik Wüllner